Jeong lab:Reprints: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
No edit summary |
(→2013) |
||
Line 24: | Line 24: | ||
* Koh KH, Pan X, Shen H, Arnold SLM, Yu AM, Gonzalez FJ, Isoherranen N, Jeong H. Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice. ''J Biol Chem'' [http://www.jbc.org/content/early/2013/12/06/jbc.M113.526798.abstract?sid=0ebc25f0-cb9c-4429-b523-18ad4dcfe8f5] | * Koh KH, Pan X, Shen H, Arnold SLM, Yu AM, Gonzalez FJ, Isoherranen N, Jeong H. Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice. ''J Biol Chem'' [http://www.jbc.org/content/early/2013/12/06/jbc.M113.526798.abstract?sid=0ebc25f0-cb9c-4429-b523-18ad4dcfe8f5] | ||
* Fischer J, Sarto GE, Hardman J, Endres L, Jenkins TM, Kilpatrick SJ, Jeong H, Geller S, Deyo K, Fischer PA, Rodvold KA. Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy. ''Clin Pharmacokinet'' | * Fischer J, Sarto GE, Hardman J, Endres L, Jenkins TM, Kilpatrick SJ, Jeong H, Geller S, Deyo K, Fischer PA, Rodvold KA. Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy. ''Clin Pharmacokinet'' [http://www.ncbi.nlm.nih.gov/pubmed/?term=24297680] | ||
* Lee H, Zhu T, Patel K, Zhang Y, Truong L, Hevener KE, Gatuz JL, Subramanya G, Jeong H, Uprichard SL, Johnson ME. High-throughput screening (HTS) and hit validation to identify small molecule inhibitors with activity against NS3/4A proteases from multiple Hepatitis C Virus genotypes. ''PlosOne'' [http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0075144] | * Lee H, Zhu T, Patel K, Zhang Y, Truong L, Hevener KE, Gatuz JL, Subramanya G, Jeong H, Uprichard SL, Johnson ME. High-throughput screening (HTS) and hit validation to identify small molecule inhibitors with activity against NS3/4A proteases from multiple Hepatitis C Virus genotypes. ''PlosOne'' 2013;8(10):e75144 [http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0075144] | ||
* Zhang Y, Liu Y, Mehboob S, Song J, Boci T, Johnson ME, Ghosh AK, Jeong H. Metabolism-directed structure optimization of benzimidazole-based Francisella tularensis enoyl-reductase (FabI) inhibitors. ''Xenobiotica'' [http:// | * Zhang Y, Liu Y, Mehboob S, Song J, Boci T, Johnson ME, Ghosh AK, Jeong H. Metabolism-directed structure optimization of benzimidazole-based Francisella tularensis enoyl-reductase (FabI) inhibitors. ''Xenobiotica'' [http://www.ncbi.nlm.nih.gov/pubmed/?term=24171690] | ||
* Zhang N, Seguin RP, Kunze KL, Zhang Y, Jeong H. Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: Implications in warfarin therapy. ''Drug Metab Dispos.'' 2013;41(12):2114-23 [http://www.ncbi.nlm.nih.gov/pubmed/?term=24046330] | * Zhang N, Seguin RP, Kunze KL, Zhang Y, Jeong H. Characterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: Implications in warfarin therapy. ''Drug Metab Dispos.'' 2013;41(12):2114-23 [http://www.ncbi.nlm.nih.gov/pubmed/?term=24046330] |
Revision as of 12:22, 7 December 2013
2013
2012
2011
2010
2009
2008 and before
|